The Sanford Guide 2020

Write a review
  • En oferta
  • Precio habitual $40.00


What's new in 2020:
  • Table 1: Osteomyelitis, meningitis, amnionitis, gastric ulcer, traveler’s diarrhea, C. difficile, keratitis, epididymo-orchitis, septic arthritis, prosthetic joint infection, pneumonia (empiric: age-determined, CAP, HAP, VAP; and specific, esp. GNB); secondary peritonitis, pharyngitis, parapharyngeal space infection, ulcerated skin, bacillary angiomatosis, thrombophlebitis
  • Table 2: Updated treatment options overview, especially gram-negative bacilli
  • Table 3: Duration of therapy: bacteremia, bone, genital, intra-abdominal, kidney
  • Table 4: New drugs and updates reflecting shifting susceptibility/resistance patterns
  • Table 5: Highly resistant bacteria, especially GNB
  • Table 6: MRSA
  • Table 7: New desensitization protocols
  • Table 8: Pregnancy risk & lactation safety for new drugs
  • Table 9: PK & interactions data for new drugs
  • Table 10: New antibacterials, including cefidericol, imipenem-cilastatin-relebactam, lefamulin and drug information for agents available in other regions, e.g., IV forsfomycin
  • Table 11: Updated recommendations, including Candida auris
  • Table 12: Updated recommendations for MDR tuberculosis and non-tuberculous mycobacteria
  • Table 13: Updated recommendations and drug availability for intestinal protozoa, malaria, trypanosomiasis, worms
  • Table 14: Adenovirus, coronavirus (2019-nCoV), Ebola, Epstein-Barr virus, neonatal herpes, influenza, measles; HIV – new ARVs
  • Table 15: Surgical prophylaxis
  • Table 16: Updated pediatric dosing for new and older drugs
  • Table 17: Renal impairment adjustments for new and some older drugs; updated obesity dosing
  • Table 22: Drug-drug interactions updates for new and existing antimicrobials